Prediction of Acute Graft versus Host Disease and Relapse by Endogenous Metabolomic Compounds in Patients Receiving Personalized Busulfan-Based Conditioning.

Autor: McCune JS; City of Hope, Department of Population Sciences, Duarte, California 91010, United States.; City of Hope, Department of Hematology & HCT, Duarte, California 91010, United States., McKiernan JS; City of Hope, Department of Population Sciences, Duarte, California 91010, United States., van Maarseveen E; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, 3584 CS Utrecht, The Netherlands., Huitema ADR; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, 3584 CS Utrecht, The Netherlands.; Department of Pharmacy & Pharmacology, Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands., Randolph TW; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States., Deeg HJ; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States.; Department of Medicine, University of Washington, Seattle, Washington 98195, United States., Nakamura R; City of Hope, Department of Hematology & HCT, Duarte, California 91010, United States., Baker KS; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington 98109, United States.; Department of Pediatrics, University of Washington, Seattle, Washington 98195, United States.

Publikováno v: Journal of proteome research [J Proteome Res] 2021 Jan 01; Vol. 20 (1), pp. 684-694. Date of Electronic Publication: 2020 Oct 16.

A phase I study of niclosamide in combination with enzalutamide in men with castration-resistant prostate cancer.

Autor: Schweizer MT; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Haugk K; Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, Washington, United States of America., McKiernan JS; Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California, United States of America., Gulati R; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA., Cheng HH; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Maes JL; Seattle Cancer Care Alliance, Seattle, Washington, United States of America., Dumpit RF; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Nelson PS; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Division of Human Biology, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., Montgomery B; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America., McCune JS; Department of Population Sciences, City of Hope Comprehensive Cancer Center, Duarte, California, United States of America., Plymate SR; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Veterans Affairs Puget Sound Health Care System, University of Washington, Seattle, Washington, United States of America., Yu EY; Department of Medicine, University of Washington, Seattle, Washington, United States of America.; Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, United States of America.

Publikováno v: PloS one [PLoS One] 2018 Jun 01; Vol. 13 (6), pp. e0198389. Date of Electronic Publication: 2018 Jun 01 (Print Publication: 2018).